Paul E. A. Glaser - Publications

Affiliations: 
Anatomy and Neurobiology University of Kentucky, Lexington, KY 
Area:
Neuroscience Biology, Developmental Psychology, Behavioral Psychology, Clinical Psychology, Pharmacology

36 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Miller EM, Quintero JE, Pomerleau F, Huettl P, Gerhardt GA, Glaser PEA. Chronic Methylphenidate Alters Tonic and Phasic Glutamate Signaling in the Frontal Cortex of a Freely-Moving Rat Model of ADHD. Neurochemical Research. PMID 29397534 DOI: 10.1007/s11064-018-2483-1  0.56
2016 Marks KR, Lile JA, Stoops WW, Glaser PE, Hays LR, Rush CR. Separate and Combined Effects of Naltrexone and Extended-Release Alprazolam on the Reinforcing, Subject-Rated, and Cardiovascular Effects of Methamphetamine. Journal of Clinical Psychopharmacology. PMID 27043121 DOI: 10.1097/JCP.0000000000000488  0.56
2015 Miller EM, Quintero JE, Pomerleau F, Huettl P, Gerhardt GA, Glaser PE. Simultaneous glutamate recordings in the frontal cortex network with multisite biomorphic microelectrodes: New tools for ADHD research. Journal of Neuroscience Methods. PMID 25614383 DOI: 10.1016/j.jneumeth.2015.01.018  0.56
2014 Leuchter AF, McGough JJ, Korb AS, Hunter AM, Glaser PE, Deldar A, Durell TM, Cook IA. Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: a pilot project. Journal of Psychiatric Research. 54: 11-8. PMID 24726639 DOI: 10.1016/j.jpsychires.2014.03.009  0.56
2014 Miller EM, Pomerleau F, Huettl P, Gerhardt GA, Glaser PE. Aberrant glutamate signaling in the prefrontal cortex and striatum of the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder. Psychopharmacology. 231: 3019-29. PMID 24682500 DOI: 10.1007/s00213-014-3479-4  0.56
2013 Durell TM, Adler LA, Williams DW, Deldar A, McGough JJ, Glaser PE, Rubin RL, Pigott TA, Sarkis EH, Fox BK. Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial. Journal of Clinical Psychopharmacology. 33: 45-54. PMID 23277268 DOI: 10.1097/JCP.0b013e31827d8a23  0.56
2012 Miller EM, Pomerleau F, Huettl P, Russell VA, Gerhardt GA, Glaser PE. The spontaneously hypertensive and Wistar Kyoto rat models of ADHD exhibit sub-regional differences in dopamine release and uptake in the striatum and nucleus accumbens. Neuropharmacology. 63: 1327-34. PMID 22960443 DOI: 10.1016/j.neuropharm.2012.08.020  0.56
2012 Stoops WW, Lile JA, Glaser PE, Hays LR, Rush CR. Influence of acute bupropion pre-treatment on the effects of intranasal cocaine. Addiction (Abingdon, England). 107: 1140-7. PMID 22168398 DOI: 10.1111/j.1360-0443.2011.03766.x  0.56
2012 Stoops WW, Lile JA, Glaser PE, Hays LR, Rush CR. Alternative reinforcer response cost impacts cocaine choice in humans. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 36: 189-93. PMID 22015480 DOI: 10.1016/j.pnpbp.2011.10.003  0.56
2012 Munro J, Skrobot O, Sanyoura M, Kay V, Susce MT, Glaser PE, de Leon J, Blakemore AI, Arranz MJ. Relaxin polymorphisms associated with metabolic disturbance in patients treated with antipsychotics. Journal of Psychopharmacology (Oxford, England). 26: 374-9. PMID 21693553 DOI: 10.1177/0269881111408965  0.56
2011 Rush CR, Stoops WW, Lile JA, Glaser PE, Hays LR. Physiological and subjective effects of acute intranasal methamphetamine during atomoxetine maintenance. Pharmacology, Biochemistry, and Behavior. 100: 40-7. PMID 21802442 DOI: 10.1016/j.pbb.2011.06.024  0.56
2011 Lile JA, Stoops WW, Glaser PE, Hays LR, Rush CR. Physiological and subjective effects of acute intranasal methamphetamine during extended-release alprazolam maintenance. Drug and Alcohol Dependence. 119: 187-93. PMID 21737214 DOI: 10.1016/j.drugalcdep.2011.06.006  0.56
2011 Sevak RJ, Vansickel AR, Stoops WW, Glaser PE, Hays LR, Rush CR. Discriminative-stimulus, subject-rated, and physiological effects of methamphetamine in humans pretreated with aripiprazole. Journal of Clinical Psychopharmacology. 31: 470-80. PMID 21694622 DOI: 10.1097/JCP.0b013e318221b2db  0.56
2011 Hascup KN, Hascup ER, Stephens ML, Glaser PE, Yoshitake T, Mathé AA, Gerhardt GA, Kehr J. Resting glutamate levels and rapid glutamate transients in the prefrontal cortex of the Flinders Sensitive Line rat: a genetic rodent model of depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 1769-77. PMID 21525860 DOI: 10.1038/npp.2011.60  0.56
2011 Rush CR, Stoops WW, Lile JA, Glaser PE, Hays LR. Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance. Psychopharmacology. 214: 665-74. PMID 21072503 DOI: 10.1007/s00213-010-2067-5  0.56
2011 Lile JA, Stoops WW, Glaser PE, Hays LR, Rush CR. Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans. Journal of Psychopharmacology (Oxford, England). 25: 1469-79. PMID 20952456 DOI: 10.1177/0269881110385597  0.56
2010 Sevak RJ, Stoops WW, Glaser PE, Hays LR, Rush CR. Reinforcing effects of d-amphetamine: influence of novel ratios on a progressive-ratio schedule. Behavioural Pharmacology. 21: 745-53. PMID 20944503 DOI: 10.1097/FBP.0b013e32833fa7b3  0.56
2010 Stoops WW, Lile JA, Glaser PE, Hays LR, Rush CR. Intranasal cocaine functions as reinforcer on a progressive ratio schedule in humans. European Journal of Pharmacology. 644: 101-5. PMID 20638380 DOI: 10.1016/j.ejphar.2010.06.055  0.56
2009 Al-Janabi I, Arranz MJ, Blakemore AI, Saiz PA, Susce MT, Glaser PE, Clark D, de Leon J. Association study of serotonergic gene variants with antipsychotic-induced adverse reactions. Psychiatric Genetics. 19: 305-11. PMID 19829168 DOI: 10.1097/YPG.0b013e3283328dcd  0.56
2009 Thomas TC, Grandy DK, Gerhardt GA, Glaser PE. Decreased dopamine D4 receptor expression increases extracellular glutamate and alters its regulation in mouse striatum. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 436-45. PMID 18536704 DOI: 10.1038/npp.2008.74  0.56
2007 Thomas TC, Kruzich PJ, Joyce BM, Gash CR, Suchland K, Surgener SP, Rutherford EC, Grandy DK, Gerhardt GA, Glaser PE. Dopamine D4 receptor knockout mice exhibit neurochemical changes consistent with decreased dopamine release. Journal of Neuroscience Methods. 166: 306-14. PMID 17449106 DOI: 10.1016/j.jneumeth.2007.03.009  0.56
2007 Joyce BM, Glaser PE, Gerhardt GA. Adderall produces increased striatal dopamine release and a prolonged time course compared to amphetamine isomers. Psychopharmacology. 191: 669-77. PMID 17031708 DOI: 10.1007/s00213-006-0550-9  0.56
2006 Lile JA, Stoops WW, Durell TM, Glaser PE, Rush CR. Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans. Experimental and Clinical Psychopharmacology. 14: 136-47. PMID 16756417 DOI: 10.1037/1064-1297.14.2.136  0.56
2006 Stoops WW, Lile JA, Glaser PE, Rush CR. A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine. Drug and Alcohol Dependence. 84: 206-9. PMID 16540264 DOI: 10.1016/j.drugalcdep.2006.02.004  0.56
2006 Glaser PE, Surgener SP, Grondin R, Gash CR, Palmer M, Castellanos FX, Gerhardt GA. Cerebellar neurotransmission in attention-deficit/hyperactivity disorder: does dopamine neurotransmission occur in the cerebellar vermis? Journal of Neuroscience Methods. 151: 62-7. PMID 16451810 DOI: 10.1016/j.jneumeth.2005.09.019  0.56
2006 Castellanos FX, Glaser PE, Gerhardt GA. Towards a neuroscience of attention-deficit/hyperactivity disorder: fractionating the phenotype. Journal of Neuroscience Methods. 151: 1-4. PMID 16427130 DOI: 10.1016/j.jneumeth.2005.11.002  0.56
2005 Lile JA, Stoops WW, Wagner FP, Glaser PE, Rush CR. Oxazepam does not modulate the behavioral effects of d-amphetamine in humans. Pharmacology, Biochemistry, and Behavior. 82: 270-9. PMID 16182353 DOI: 10.1016/j.pbb.2005.08.012  0.56
2005 Lile JA, Stoops WW, Vansickel AR, Glaser PE, Hays LR, Rush CR. Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 2103-14. PMID 15988473 DOI: 10.1038/sj.npp.1300803  0.56
2005 Stoops WW, Lile JA, Fillmore MT, Glaser PE, Rush CR. Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration. Psychopharmacology. 182: 186-93. PMID 15986191 DOI: 10.1007/s00213-005-0044-1  0.56
2005 Rush CR, Higgins ST, Vansickel AR, Stoops WW, Lile JA, Glaser PE. Methylphenidate increases cigarette smoking. Psychopharmacology. 181: 781-9. PMID 15983792 DOI: 10.1007/s00213-005-0021-8  0.56
2005 Stoops WW, Lile JA, Glaser PE, Rush CR. Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans. Experimental and Clinical Psychopharmacology. 13: 56-64. PMID 15727504 DOI: 10.1037/1064-1297.13.1.56  0.56
2005 Glaser PE, Thomas TC, Joyce BM, Castellanos FX, Gerhardt GA. Differential effects of amphetamine isomers on dopamine release in the rat striatum and nucleus accumbens core. Psychopharmacology. 178: 250-8. PMID 15719230 DOI: 10.1007/s00213-004-2012-6  0.56
2005 Stoops WW, Lile JA, Fillmore MT, Glaser PE, Rush CR. Reinforcing effects of methylphenidate: influence of dose and behavioral demands following drug administration. Psychopharmacology. 177: 349-55. PMID 15609070 DOI: 10.1007/s00213-004-1946-z  0.56
2004 Stoops WW, Glaser PE, Fillmore MT, Rush CR. Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans. Journal of Psychopharmacology (Oxford, England). 18: 534-43. PMID 15582920 DOI: 10.1177/0269881104047281  0.56
2004 Lile JA, Stoops WW, Glaser PE, Hays LR, Rush CR. Acute administration of the GABA reuptake inhibitor tiagabine does not alter the effects of oral cocaine in humans. Drug and Alcohol Dependence. 76: 81-91. PMID 15380292 DOI: 10.1016/j.drugalcdep.2004.04.010  0.56
2004 Lile JA, Stoops WW, Allen TS, Glaser PE, Hays LR, Rush CR. Baclofen does not alter the reinforcing, subject-rated or cardiovascular effects of intranasal cocaine in humans. Psychopharmacology. 171: 441-9. PMID 14504683 DOI: 10.1007/s00213-003-1598-4  0.56
Show low-probability matches.